Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis

Tofacitinib for rescue therapy in acute severe ulcerative colitis: a real-world experience

(2020) Prashant Kotwani et al.   Journal of Crohns & Colitis

P512 Efficacy of tofacitinib for the treatment of moderate-to-severe ulcerative colitis: real-world data

(2020) Y XIAO et al.   Journal of Crohns & Colitis

P648 Efficacy including rapid response and safety of tofacitinib in Japanese patients with ulcerative colitis: A preliminary investigation in a specialised IBD centre

(2020) K Watanabe et al.   Journal of Crohns & Colitis

P662 Efficacy and safety of tofacitinib in patients with moderate-to-severe ulcerative colitis: A real-world retrospective study

(2020) N Yoshimura et al.   Journal of Crohns & Colitis

P663 Efficacy of tofacitinib in patients with ulcerative colitis after previous ineffective biological therapies

(2020) M Rutka et al.   Journal of Crohns & Colitis

Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry

(2020) Vince B. C. Biemans et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Tu1895 TOFACITINIB INDUCES CLINICAL AND ENDOSCOPIC REMISSION IN BIOLOGIC REFRACTORY ULCERATIVE COLITIS PATIENTS: A REAL-WORLD BELGIUM COHORT STUDY

(2020) Anneline Cremer et al.   GASTROENTEROLOGY

Mo1858 ENDOSCOPIC AND HISTOLOGIC OUTCOME IN TOFACITINIB TREATED REFRACTORY MODERATE-TO-SEVERE ULCERATIVE COLITIS: A PROSPECTIVE REAL-LIFE COHORT

(2020) Bram Verstockt et al.   GASTROENTEROLOGY

Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience

(2020) Sailish Honap et al.   Journal of Crohns & Colitis

Tofacitinib in Acute Severe Ulcerative Colitis—A Real-World Tertiary Center Experience

(2020) Sailish Honap et al.   INFLAMMATORY BOWEL DISEASES

Real-World Experience with Tofacitinib in IBD at a Tertiary Center

(2019) Roni Weisshof et al.   DIGESTIVE DISEASES AND SCIENCES

797 – Real-World Safety of Tofacitinib in Inflammatory Bowel Diseases: A Multi-Center Study

(2019) Parakkal Deepak et al.   GASTROENTEROLOGY

796 – Real-World Effectiveness of Tofacitinib in Ulcerative Colitis; a Multi-Center Study

(2019) Anish Patel et al.   GASTROENTEROLOGY

Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open

(2019) Bruce E. Sands et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

(2019) Loriane Lair-Mehiri et al.   DIGESTIVE AND LIVER DISEASE

Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease

(2018) Stefan Schreiber et al.   JOURNAL OF GASTROENTEROLOGY

Efficacy of Induction Therapy with High-intensity Tofacitinib in 4 Patients with Acute Severe Ulcerative Colitis

(2018) Jeffrey A. Berinstein et al.   Clinical Gastroenterology and Hepatology

Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials

(2018) William J. Sandborn et al.   Clinical Gastroenterology and Hepatology

Effectiveness of golimumab in ulcerative colitis: A review of the real world evidence

(2018) Pablo Olivera et al.   DIGESTIVE AND LIVER DISEASE

Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

(2017) Carlos Taxonera et al.   INFLAMMATORY BOWEL DISEASES

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

(2017) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation

(2016) Carlos Taxonera et al.   DIGESTIVE DISEASES AND SCIENCES

Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor

(2016) Christina Charles-Schoeman et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

(2015) L Peyrin-Biroulet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Update on Janus Kinase Antagonists in Inflammatory Bowel Disease

(2014) Brigid S. Boland et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases

(2014) James D. Clark et al.   JOURNAL OF MEDICINAL CHEMISTRY

Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies

(2014) J. Wollenhaupt et al.   JOURNAL OF RHEUMATOLOGY

Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

(2013) William J. Sandborn et al.   GASTROENTEROLOGY

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

(2013) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

(2011) William J. Sandborn et al.   GASTROENTEROLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE